R(+)-8-OH-DPAT, a selective 5-HT1A receptor agonist, attenuated amphetamine-induced dopamine synthesis in rat striatum, but not nucleus accumbens or medial prefrontal cortex

被引:9
作者
Kuroki, T
Dai, J
Meltzer, HY
Ichikawa, J
机构
[1] Vanderbilt Univ, Sch Med, Dept Psychiat, Psychopharmacol Div,Floor Lab 1, Nashville, TN 37212 USA
[2] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA
关键词
R(+)-8-OH-DPAT; 5-HT1A receptor; D-amphetamine; dopamine synthesis; rat;
D O I
10.1016/S0006-8993(00)02437-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
R(+)-8-OH-DPAT (0.05, but not 0.025, 0.1, 1 mg/kg), a 5-HT1A receptor agonist, decreased l-3,4-dihydroxyphenylalanine (DOPA) accumulation in rat striatum following NSD-1015, an l-aromatic amino acid decarboxylase inhibitor. Amphetamine (1 mg/kg) increased striatal DOPA accumulation, an effect attenuated by R(+)-8-OH-DPAT (0.05 mg/kg). However, both amphetamine (1 mg/kg) and R(+)-8-OH-DPAT (0.05 mg/kg) decreased cortical DOPA accumulation; there were no additional decreases from their combination. Neither amphetamine (1 mg/kg), R(+)-8-OH-DPAT (0.05 mg/kg), or the combination, significantly affected DOPA accumulation in the nucleus accumbens. The significance of and possible mechanisms for these findings are discussed. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:204 / 207
页数:4
相关论文
共 22 条
[1]   In vivo intrinsic efficacy of the 5-HT1A receptor antagonists NAD-299, WAY-100,635 and (S)-(-)-UH-301 at rat brain monoamine receptors [J].
Ahlenius, S ;
Henriksson, I ;
Magnusson, O ;
Salmi, P .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1999, 9 (1-2) :15-19
[2]   EVIDENCE FOR SELECTIVE-INHIBITION OF LIMBIC FOREBRAIN DOPAMINE SYNTHESIS BY 8-OH-DPAT IN THE RAT [J].
AHLENIUS, S ;
HILLEGAART, V ;
WIJKSTROM, A .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1989, 339 (05) :551-556
[3]   (R)-8-OH-DPAT PREFERENTIALLY INCREASES DOPAMINE RELEASE IN RAT MEDIAL PREFRONTAL CORTEX [J].
ARBORELIUS, L ;
NOMIKOS, GG ;
HACKSELL, U ;
SVENSSON, TH .
ACTA PHYSIOLOGICA SCANDINAVICA, 1993, 148 (04) :465-466
[4]  
BJORK L, 1989, J MED CHEM, V32, P779
[5]   AMPHETAMINE-INDUCED DOPAMINE RELEASE IN THE RAT STRIATUM - AN INVIVO MICRODIALYSIS STUDY [J].
BUTCHER, SP ;
FAIRBROTHER, IS ;
KELLY, JS ;
ARBUTHNOTT, GW .
JOURNAL OF NEUROCHEMISTRY, 1988, 50 (02) :346-355
[6]   STRIATAL SYNAPTOSOMAL DOPAMINE SYNTHESIS - EVIDENCE AGAINST DIRECT REGULATION BY AN AUTORECEPTOR MECHANISM [J].
COMPTON, DR ;
JOHNSON, KM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 110 (02) :157-162
[7]   A PHARMACOLOGICAL PROFILE OF THE SELECTIVE SILENT 5-HT1A RECEPTOR ANTAGONIST, WAY-100635 [J].
FORSTER, EA ;
CLIFFE, IA ;
BILL, DJ ;
DOVER, GM ;
JONES, D ;
REILLY, Y ;
FLETCHER, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (01) :81-88
[8]  
Franklin K, 2012, MOUSE BRAIN STEREOTA
[9]   R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens [J].
Ichikawa, J ;
Kuroki, T ;
Kitchen, MT ;
Meltzer, HY .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 287 (02) :179-184
[10]  
Ichikawa J, 1999, J PHARMACOL EXP THER, V291, P1227